Cargando…
The Influence of Coumestrol on Sphingolipid Signaling Pathway and Insulin Resistance Development in Primary Rat Hepatocytes
Coumestrol is a phytoestrogen widely known for its anti-diabetic, anti-oxidant, and anti-inflammatory properties. Thus, it gets a lot of attention as a potential agent in the nutritional therapy of diseases such as obesity and type 2 diabetes. In our study, we evaluated whether coumestrol affects in...
Autores principales: | Zywno, Hubert, Bzdega, Wiktor, Kolakowski, Adrian, Kurzyna, Piotr, Harasim-Symbor, Ewa, Sztolsztener, Klaudia, Chabowski, Adrian, Konstantynowicz-Nowicka, Karolina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7918648/ https://www.ncbi.nlm.nih.gov/pubmed/33673122 http://dx.doi.org/10.3390/biom11020268 |
Ejemplares similares
-
Vitamin K2 as a New Modulator of the Ceramide De Novo Synthesis Pathway
por: Kołakowski, Adrian, et al.
Publicado: (2021) -
How Does CBG Administration Affect Sphingolipid Deposition in the Liver of Insulin-Resistant Rats?
por: Bzdęga, Wiktor, et al.
Publicado: (2023) -
Time-Dependent Changes in Hepatic Sphingolipid Accumulation and PI3K/Akt/mTOR Signaling Pathway in a Rat Model of NAFLD
por: Sztolsztener, Klaudia, et al.
Publicado: (2021) -
Molecular Advances in MAFLD—A Link between Sphingolipids and Extracellular Matrix in Development and Progression to Fibrosis
por: Kołakowski, Adrian, et al.
Publicado: (2022) -
The Endocannabinoid System and Physical Activity—A Robust Duo in the Novel Therapeutic Approach against Metabolic Disorders
por: Charytoniuk, Tomasz, et al.
Publicado: (2022)